Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-88.85%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 0.79Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information
Ticker
XLOCompany Name
XILIO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQXILIO THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XLO - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -13.33M | -88.85% | $ 15M |
| 3/31/2025 | $ 21.1M | 227.54% | $ 9.27M |
| 12/31/2024 | $ -18.38M | -289.69% | $ 6.34M |
| 9/30/2024 | $ -17.65M | -381.99% | $ 4.62M |
| 6/30/2024 | $ -17.34M | -735.89% | $ 2.36M |
| 3/31/2024 | $ -53.87M | 0% | $ 0 |
| 12/31/2023 | $ -68.62M | 0% | $ 0 |
| 9/30/2023 | $ -73.42M | 0% | $ 0 |
| 6/30/2023 | $ -79.96M | 0% | $ 0 |
| 3/31/2023 | $ -80.14M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
- Over the past 5 years, XILIO THERAPEUTICS INC's average OCF % has been -253.78%.
- The median OCF % for XILIO THERAPEUTICS INC during this period was -289.69%
- XILIO THERAPEUTICS INC reached its highest OCF % over the past 5 years at 227.54%.
- The lowest OCF % recorded by XILIO THERAPEUTICS INC in the same timeframe -735.89%
XILIO THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for XILIO THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -36.09M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ] XLO - Operating Cash Flow Margin, Last 5 years
-735.89%
Minimum
Jun 30, 2024
227.54%
Maximum
Mar 31, 2025
-253.78%
Average
-289.69%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |